bit.bio raises €7.7M Seed round
27 March 2019· Cambridge, United Kingdom· health, biotech, ai, b2b, deep_hardware
To create a high-throughput research platform to identify transcription factor combinations for cell type programs.
Investors
LeadBlueYard Capital
About bit.bio
Stage
Series C
Headquarters
Cambridge, United Kingdom
Founded
2016
Team Size
201–500
Sectors
healthbiotechaib2bdeep_hardware
Source: https://medium.com/blueyard/bit-bio-as-we-reach-the-read-write-stage-of-biology-2d64f0f62d1a